223 related articles for article (PubMed ID: 3821916)
1. Radioimmunoimaging in malignant melanoma patients with the use of indium-111-labeled antimelanoma monoclonal antibody (ZME-018) to high-molecular-weight antigen.
Murray JL; Rosenblum MG; Lamki L; Haynie TP; Glenn HJ; Plager CE; Unger MW; Carlo DJ; Hersh EM
NCI Monogr; 1987; (3):3-9. PubMed ID: 3821916
[TBL] [Abstract][Full Text] [Related]
2. Clinical parameters related to optimal tumor localization of indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018.
Murray JL; Rosenblum MG; Lamki L; Glenn HJ; Krizan Z; Hersh EM; Plager CE; Bartholomew RM; Unger MW; Carlo DJ
J Nucl Med; 1987 Jan; 28(1):25-33. PubMed ID: 3794809
[TBL] [Abstract][Full Text] [Related]
3. [Radioimmunoimaging of malignant melanoma with In-111 labeled monoclonal antibody 96.5 and ZME-0.18].
Ishii K; Nishiyama S; Oyamada H; Endo K
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1194-203. PubMed ID: 2730019
[TBL] [Abstract][Full Text] [Related]
4. Scintigraphic detection of metastatic melanoma using indium 111/DTPA conjugated anti-gp240 antibody (ZME-018).
Kirkwood JM; Neumann RD; Zoghbi SS; Ernstoff MS; Cornelius EA; Shaw C; Ziyadeh T; Fine JA; Unger MW
J Clin Oncol; 1987 Aug; 5(8):1247-55. PubMed ID: 3625247
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunoimaging in malignant melanoma with 111In-labeled monoclonal antibody 96.5.
Murray JL; Rosenblum MG; Sobol RE; Bartholomew RM; Plager CE; Haynie TP; Jahns MF; Glenn HJ; Lamki L; Benjamin RS
Cancer Res; 1985 May; 45(5):2376-81. PubMed ID: 3986779
[TBL] [Abstract][Full Text] [Related]
6. Sequential use of indium-111 labeled monoclonal antibodies 96.5 and ZME-018 does not increase detection sensitivity for metastatic melanoma.
Frontiera M; Murray JL; Lamki L; Thomas J; Satterlee W; Schmelter R; Rosenblum MG; Khazaeli MB; Unger MW; Robinson WA
Clin Nucl Med; 1989 May; 14(5):357-66. PubMed ID: 2656042
[TBL] [Abstract][Full Text] [Related]
7. Immunoscintigraphy and pharmacokinetics of indium-111-labeled ZME-018 monoclonal antibody in patients with malignant melanoma.
Koizumi M; Endo K; Watanabe Y; Saga T; Sakahara H; Konishi J; Arano Y; Miyachi Y; Kashihara-Sawami M; Imamura S
Jpn J Cancer Res; 1988 Aug; 79(8):973-81. PubMed ID: 3141332
[TBL] [Abstract][Full Text] [Related]
8. Immunospecific saturable clearance mechanisms for indium-111-labeled anti-melanoma monoclonal antibody 96.5 in humans.
Murray JL; Lamki LM; Shanken LJ; Blake ME; Plager CE; Benjamin RS; Schweighardt S; Unger MW; Rosenblum MG
Cancer Res; 1988 Aug; 48(15):4417-22. PubMed ID: 3390837
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunodetection of human melanoma with indium-111-labeled monoclonal antibody.
Taylor A; Milton W; Eyre HP; Christian P; Wu F; Hagan P; Alazraki N; Datz FL; Unger M
J Nucl Med; 1988 Mar; 29(3):329-37. PubMed ID: 3346743
[TBL] [Abstract][Full Text] [Related]
10. Comparison of gallium-67 versus indium-111 monoclonal antibody (96.5, ZME-018) in detection of human melanoma in athymic mice.
Chan SM; Hoffer PB; Maric N; Zoghbi SS; Kirkwood JM; Ernstoff MS; Duray PH; Gerich B
J Nucl Med; 1987 Sep; 28(9):1441-6. PubMed ID: 3476691
[TBL] [Abstract][Full Text] [Related]
11. Comparative clinical pharmacology of [111In]-labeled murine monoclonal antibodies.
Rosenblum MG; Murray JL; Lamki L; David G; Carlo D
Cancer Chemother Pharmacol; 1987; 20(1):41-7. PubMed ID: 3621452
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody imaging of human melanoma. Radioimmunodetection by subcutaneous or systemic injection.
Lotze MT; Carrasquillo JA; Weinstein JN; Bryant GJ; Perentesis P; Reynolds JC; Matis LA; Eger RR; Keenan AM; Hellström I
Ann Surg; 1986 Sep; 204(3):223-35. PubMed ID: 3753057
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of 111In-labeled anti-p97 monoclonal antibody in patients with metastatic malignant melanoma.
Rosenblum MG; Murray JL; Haynie TP; Glenn HJ; Jahns MF; Benjamin RS; Frincke JM; Carlo DJ; Hersh EM
Cancer Res; 1985 May; 45(5):2382-6. PubMed ID: 3986780
[TBL] [Abstract][Full Text] [Related]
14. Effect of antibody dose on the imaging and biodistribution of indium-111 9.2.27 anti-melanoma monoclonal antibody.
Carrasquillo JA; Abrams PG; Schroff RW; Reynolds JC; Woodhouse CS; Morgan AC; Keenan AM; Foon KA; Perentesis P; Marshall S
J Nucl Med; 1988 Jan; 29(1):39-47. PubMed ID: 3335926
[TBL] [Abstract][Full Text] [Related]
15. Uptake of indium-111-labeled monoclonal antibody ZME-018 as a function of tumor size in a patient with melanoma.
Macey DJ; Denardo SJ; Denardo GL; Goodnight JK; Unger MW
Am J Physiol Imaging; 1988; 3(1):1-6. PubMed ID: 3390350
[TBL] [Abstract][Full Text] [Related]
16. Immunoreactivity and biodistribution of indium-111-labeled monoclonal antibody to a human high molecular weight-melanoma associated antigen.
Fawwaz RA; Wang TS; Estabrook A; Rosen JM; Hardy MA; Alderson PO; Srivastava SC; Richards P; Ferrone S
J Nucl Med; 1985 May; 26(5):488-92. PubMed ID: 3989605
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunodetection of human melanoma with indium-111-labeled monoclonal antibodies.
Taylor A; Milton W; Eyre H; Wu FP; Christian P; Alazraki N; Datz F; Unger MW
NCI Monogr; 1987; (3):25-31. PubMed ID: 3821915
[TBL] [Abstract][Full Text] [Related]
18. Targeting of indium 111-labeled bivalent hapten to human melanoma mediated by bispecific monoclonal antibody conjugates: imaging of tumors hosted in nude mice.
Le Doussal JM; Gruaz-Guyon A; Martin M; Gautherot E; Delaage M; Barbet J
Cancer Res; 1990 Jun; 50(11):3445-52. PubMed ID: 2334941
[TBL] [Abstract][Full Text] [Related]
19. Kinetic model for the biodistribution of an 111In-labeled monoclonal antibody in humans.
Eger RR; Covell DG; Carrasquillo JA; Abrams PG; Foon KA; Reynolds JC; Schroff RW; Morgan AC; Larson SM; Weinstein JN
Cancer Res; 1987 Jun; 47(12):3328-36. PubMed ID: 3581071
[TBL] [Abstract][Full Text] [Related]
20. Phase 1 immunolymphoscintigraphy with an In-111-labeled antimelanoma monoclonal antibody.
Engelstad BL; Spitler LE; Del Rio MJ; Ramos EC; Rosendorf LL; Reinhold CE; Khentigan A; Huberty JP; Corpuz SW; Lee HM
Radiology; 1986 Nov; 161(2):419-22. PubMed ID: 3763912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
